Doseology Sciences, Inc. (TSE:MOOD) has released an update.
Doseology Sciences Inc., a functional mushroom supplement company, has appointed Christopher P. Cherry as the Interim CEO while maintaining his CFO role. This move is part of a broader executive realignment aimed at driving the company’s future expansion. The firm has also bolstered its board with the addition of Zara Kanji and Cary Alexander Kazemi, who bring extensive financial and international business experience, respectively.
For further insights into TSE:MOOD stock, check out TipRanks’ Stock Analysis page.
